By integrating peripheral metabolic signals with hypothalamic neuroendocrine circuits, ghrelin and its endogenous antagonist LEAP2 dynamically regulate feeding behaviour, glucose counter-regulation, and metabolic adaptation to fasting and nutrient availability
Do not stop, restart, or change your dose without medical guidance
Time your injection wisely
Clinical studies indicate that individuals may lose between 5% and 15% of their initial body weight over a few months when combining Semaglutide GLP-1 with a reduced-calorie diet and increased physical activity
This is the same recommendation the American Heart Association makes for cardiovascular health, but it has direct benefits for gut motility too
These appointments provide an opportunity to discuss any persistent side effects and explore potential adjustments in treatment